HIV阳性成人接种2剂或3剂甲肝疫苗的长期免疫持久性
这项前瞻性非随机队列研究评估了18-40岁接受抗逆转录病毒治疗的HIV阳性男男性行为者接种2剂或3剂甲肝疫苗后5年内的抗体持久性。5年末,3剂组与2剂组的血清保护率在意向性分析和符合方案分析中分别为79% vs 76%和94% vs 88%(P > .05),但3剂组抗HAV IgG几何平均浓度显著更高,且3剂方案与持续血清保护独立相关(OR=3.36;95%CI 1.14-9.93)。
要点
- HIV阳性成人接种3剂甲肝疫苗后5年血清保护率与2剂组无显著差异。
- 3剂组抗HAV IgG几何平均浓度在整个5年中显著高于2剂组。
- 3剂方案是持续血清保护的独立相关因素(OR=3.36;95%CI 1.14-9.93)。
核心结论
- 与2剂相比,3剂甲肝疫苗可提高HIV阳性成人特异性IgG浓度并延长衰减至阈值以下的时间。
研究设计与样本
- 前瞻性非随机队列研究,纳入18-40岁接受抗逆转录病毒治疗的HIV阳性男男性行为者,按0-6或0-1-6月程序接种2或3剂甲肝疫苗,每半年评估抗体至5年。
主要发现
- 5年末意向性分析血清保护率3剂组79%(146/185)vs 2剂组76%(85/110),P > .05。
- 5年末符合方案分析血清保护率3剂组94%(146/155)vs 2剂组88%(84/95),P > .05。
- 整个5年中3剂组抗HAV IgG几何平均浓度显著高于2剂组。
- 多变量分析中3剂vs 2剂与持续血清保护独立相关(OR=3.36;95%CI 1.14-9.93)。
临床怎么用
- 对HIV阳性成人可考虑采用3剂甲肝疫苗接种方案以增强长期免疫持久性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous studies have shown that the durability of serological response is impaired in successfully vaccinated human immunodeficiency virus-1 (HIV-1) positive subjects after receiving 2 doses of inactivated hepatitis A virus (HAV) vaccine. We evaluated whether 3 doses compared with 2 doses of HAV vaccine could improve the long-term seroprotection for this susceptible group. METHODS: Antibody persistence among HIV-positive men who have sex with men aged 18-40 years who had received 2 or 3 doses of HAV vaccine according to a 0-6- or a 0-1-6-month schedule was evaluated biannually for 5 consecutive years in this prospective, nonrandomized cohort study. RESULTS: At the end of 5 years, seroprotection persisted in 79% (146/185) versus 76% (85/110) and 94% (146/155) versus 88% (84/95) of the 3- versus 2-dose primary responders by intention-to-treat and per-protocol analyses, respectively (P > .05). Throughout the 5 years, the geometric mean concentrations of anti-HAV immunoglobulin G (IgG) were significantly higher for the 3-dose than the 2-dose group. In the multivariable analysis, a 3-dose regimen compared with a 2-dose regimen (odds ratio = 3.36; 95% confidence interval = 1.14-9.93) was independently associated with sustained seroprotection. CONCLUSIONS: Three doses versus 2 doses of HAV vaccine improve the durability of immune responses in terms of higher concentrations of specific IgG, which take longer to decay to subthreshold levels.
引用
- Cheng A, Chang SY, Sun HY, et al. Long-term Durability of Responses to 2 or 3 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus-Positive Adults on Antiretroviral Therapy. J Infect Dis. 2017. PMID: 28011921. doi:10.1093/infdis/jiw605
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。